These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30195449)

  • 1. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
    Hanauer SB; Sandborn WJ; Lichtenstein GR
    Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate for inflammatory bowel disease: time for reconsideration.
    Nielsen OH; Ainsworth MA; Steenholdt C
    Expert Rev Gastroenterol Hepatol; 2019 May; 13(5):407-409. PubMed ID: 30895827
    [No Abstract]   [Full Text] [Related]  

  • 3. Thiopurines in inflammatory bowel disease revisited.
    Bär F; Sina C; Fellermann K
    World J Gastroenterol; 2013 Mar; 19(11):1699-706. PubMed ID: 23555158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
    Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
    Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy.
    Balram B; Lubov J; Theoret Y; Afif W; Bitton A; Wild G; Lakatos PL; Bessissow T
    Dig Dis Sci; 2021 May; 66(5):1650-1657. PubMed ID: 32591969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a role for thioguanine therapy in IBD in 2017 and beyond?
    Taylor KM; Ward MG; Blaker PA; Sparrow MP
    Expert Rev Gastroenterol Hepatol; 2017 May; 11(5):473-486. PubMed ID: 28276819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
    Renna S; Cottone M; Orlando A
    World J Gastroenterol; 2014 Aug; 20(29):9675-90. PubMed ID: 25110407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine-induced pancreatitis in inflammatory bowel diseases.
    Ledder O; Lemberg DA; Day AS
    Expert Rev Gastroenterol Hepatol; 2015 Apr; 9(4):399-403. PubMed ID: 25494551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thiopurines in inflammatory bowel disease.
    Frei P; Biedermann L; Nielsen OH; Rogler G
    World J Gastroenterol; 2013 Feb; 19(7):1040-8. PubMed ID: 23467510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thiopurine therapy in inflammatory bowel disease.
    Ha C; Dassopoulos T
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
    Johnson CM; Dassopoulos T
    Curr Gastroenterol Rep; 2018 Sep; 20(11):53. PubMed ID: 30267281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Mercaptopurine for Azathioprine Intolerant Inflammatory Bowel Disease: Literature Search and Reappraisal of Own Data.
    Actis GC; Pellicano R; Rosina F
    Inflamm Allergy Drug Targets; 2015; 14(2):133-7. PubMed ID: 26728773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory Bowel Disease - Non-biological treatment.
    Magro F; Cordeiro G; Dias AM; Estevinho MM
    Pharmacol Res; 2020 Oct; 160():105075. PubMed ID: 32653651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert opinion: experience with 6-mercaptopurine in the treatment of inflammatory bowel disease.
    Korelitz BI
    World J Gastroenterol; 2013 May; 19(20):2979-84. PubMed ID: 23716977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thiopurine monotherapy is effective in ulcerative colitis but significantly less so in Crohn's disease: long-term outcomes for 11 928 patients in the UK inflammatory bowel disease bioresource.
    Stournaras E; Qian W; Pappas A; Hong YY; Shawky R; ; Raine T; Parkes M;
    Gut; 2021 Apr; 70(4):677-686. PubMed ID: 33004550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biological therapy as treatment of inflammatory bowel diseases].
    Agnholt J
    Ugeskr Laeger; 2008 Jun; 170(24):2152-6. PubMed ID: 18565302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of methotrexate in patients with inflammatory bowel diseases.
    Preiss JC; Zeitz M
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S151-5. PubMed ID: 21044450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infliximab Is Not Associated With Increased Risk of Malignancy or Hemophagocytic Lymphohistiocytosis in Pediatric Patients With Inflammatory Bowel Disease.
    Hyams JS; Dubinsky MC; Baldassano RN; Colletti RB; Cucchiara S; Escher J; Faubion W; Fell J; Gold BD; Griffiths A; Koletzko S; Kugathasan S; Markowitz J; Ruemmele FM; Veereman G; Winter H; Masel N; Shin CR; Tang KL; Thayu M
    Gastroenterology; 2017 Jun; 152(8):1901-1914.e3. PubMed ID: 28193515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events in IBD therapy: the 2018 update.
    Quezada SM; McLean LP; Cross RK
    Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1183-1191. PubMed ID: 30791788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.